Trial Profile
A phase III study of bortezomib in patients with relapsed diffuse large B-cell lymphoma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Jan 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 28 Jan 2015 New trial record